Kirsten Flowers
2020
In 2020, Kirsten Flowers earned a total compensation of $2.9M as Chief Commercial Officer at Kura Oncology.
Compensation breakdown
| Non-Equity Incentive Plan | $217,973 |
|---|---|
| Option Awards | $2,293,025 |
| Salary | $420,368 |
| Other | $17,026 |
| Total | $2,948,392 |
Flowers received $2.3M in option awards, accounting for 78% of the total pay in 2020.
Flowers also received $218K in non-equity incentive plan, $420.4K in salary and $17K in other compensation.
Rankings
In 2020, Kirsten Flowers' compensation ranked 3,921st out of 13,090 executives tracked by ExecPay. In other words, Flowers earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,921 out of 13,090 | 70th |
Division Manufacturing | 1,564 out of 5,624 | 72nd |
Major group Chemicals And Allied Products | 591 out of 2,257 | 74th |
Industry group Drugs | 509 out of 1,957 | 74th |
Industry Pharmaceutical Preparations | 385 out of 1,462 | 74th |
Pay ratio
| Kirsten Flowers' Pay | $2,948,392 |
|---|---|
| Median Employee's Pay | $346,674 |
| Pay Ratio | 9to 1 |
In 2020, the annual total compensation of Kirsten Flowers was $2,948,392.
The annual total compensation of the median employee at Kura Oncology was $346,674.
The ratio of Kirsten Flowers' pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on April 29, 2021.
Flowers' colleagues
We found five more compensation records of executives who worked with Kirsten Flowers at Kura Oncology in 2020.